Although it is an effective and convenient weight loss medication, Wegovy may not be suitable for everyone
All intervention and placebo groups received subcutaneous semaglutide 2.4 mg injections once weekly
Compared with normal renal function, the estimated ratio of the mean AUC 0 was 1.23 (90% confidence interval [CI], 0.911.66) in mild impairment, 1.18 (0.871.59) in moderate impairment and 1.21 (0.871.68) in severe impairment
Elaine Bradley, operations manager at Turning Point Scotland, said: Weve definitely seen an increase in the use of this drug in recent times
(PubMed) Tamilselvan J, Jayaraman G, Sivarajan K, Panneerselvam C
Incretin mimetics like these are already known for their potential gastrointestinal side effectsnausea, vomiting, and diarrhea are common, especially during initial titration